Clofarabine for Langerhans in Pedi

NCT01796405 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis

Interventions

DRUG: Clofarabine

Sponsor

Dana-Farber Cancer Institute